Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts
Co. Silva et al., Effects of long-term pretreatment with isoproterenol on inotropic responsiveness to alpha-adrenoceptor stimulation: study in isolated perfused rat hearts, J PHARM PHA, 53(2), 2001, pp. 233-242
The effects of chronic pretreatment with isoproterenol (5 mg kg(-1)) daily
for 10 days on cardiac alpha -adrenergic responsiveness in Langendorff hear
t preparations were investigated. Isoproterenol pretreatment ca used cardia
c hypertrophy (29 %) as shown by a significant increase in the ratio of ven
tricular dry weight to body weight. In preparations from isoproterenol-pret
reated rats, both maximum increases in left ventricular systolic pressure a
nd heart rate elicited by isoproterenol (10(-12) to 10(-4) M) were signific
antly reduced (the isoproterenol concentration producing 50 % of the maximu
m positive inotropic and chronotropic responses was enhanced almost 32- and
4-fold, respectively), while the positive inotropic response to phenylephr
ine (10(-12) to 10(-4) M) was significantly enhanced (the phenylephrine con
centration producing 50% of the maximum positive inotropic effect was reduc
ed almost 100-fold), compared with saline-pretreated rats. In preparations
from both groups, phenylephrine infusion induced non-significant changes in
heart rate and its positive inotropic response was reduced in the presence
of propranolol (10(-7) M) in the perfusion medium. Even under beta -adreno
ceptor blockade, the curve for the phenylephrine-induced positive inotropic
effect remained shifted upward after isoproterenol pretreatment. Chronic i
soproterenol pretreatment induces the expected cardiac beta -adrenoceptor d
esensitization while simultaneously enhancing the positive inotropic respon
siveness to phenylephrine in Langendorff heart preparations. These findings
support the hypothesis that cardiac alpha (1)-adrenoceptor stimulation may
contribute to the maintenance of myocardial function under conditions in w
hich beta -adrenoceptor function is compromised.